Canadian International Pharma Corp. Directors Participates in a Gypsy Swap

News Release No: 17-03

Trading symbol: TSX-NEX: CIP.H

Canadian International Pharma Corp. Directors Participates in a Gypsy Swap

West Vancouver, British Columbia – June 1, 2017 – Canadian International Pharma Corp. (the

“Company” or “CIPC”) announces that certain directors and officers of the Company have collectively

sold 2,000,000 shares of the Company on June 1, 2017 , and subsequently will be subscribing for

2,000,000 units in the non -brokered private placement financing announced in the Company’s news

release dated May 24, 2017.

For further information, contact Mr. Clive Shallow, Shareholder Communications, at 604-922-2030 or visit

the Company’s website at www.canpharmacorp.ca

CANADIAN INTERNATIONAL PHARMA CORP.

“Douglas L. Mason”

_____________________________________

Douglas L. Mason, CEO

Neither the TSX Venture Exchange nor its Regulation Services provider (as that term is defined in the policies of

the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release